Inhibitors of human immunodeficiency virus replication
US7956068B2 · kind B2 · utility
7Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 3, 2008 |
| Grant date | Jun 7, 2011 |
| Priority date | — |
| Expiry date | Nov 3, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula (I)wherein c, X, Y, R2, R3, R4 and R6 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV integrase, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.